Yahoo Web Search

Search results

  1. The PROMETHEUS ® IBD sgi Diagnostic ® is the 4th-generation IBD diagnostic test and the first and only test to combine serologic, genetic, and inflammation markers in the proprietary Smart Diagnostic Algorithm for added diagnostic clarity.

  2. Combines serologic, genetic, and inflammation markers to help differentiate Inflammatory Bowel Disease (IBD) vs non-IBD and ulcerative colitis (UC) vs Crohn's disease (CD). The PROMETHEUS IBD sgi Diagnostic is the 4th-generation IBD diagnostic test and the first and only test to combine serologic, genetic, and inflammation markers in the ...

  3. People also ask

  4. Mar 8, 2012 · Overall performance of PROMETHEUS IBD sgi Diagnostic: Sensitivity IBD 74%, CD 89%, UC 98%; Specificity IBD 90%, CD 81%, UC 83%. Smart Diagnostic Algorithm technology was trained (n=1083; 39% CD, 21% UC, 29% disease controls, and 11% healthy controls) and validated (n=437; 35% CD, 23% UC, 28% disease controls, and 14% healthy controls) from ...

  5. Jun 1, 2010 · OBJECTIVE: The goal was to compare the predictive values of the Prometheus Inflammatory Bowel Disease (IBD) Serology 7 (IBD7) panel (Prometheus Laboratories, San Diego, CA) with the predictive values of routine blood tests in a population of children referred for initial evaluation of suspected IBD.

    • Shira Benor, George H Russell, Michael Silver, Esther J Israel, Qian Yuan, Harland S Winter
    • 2010
  6. Jul 10, 2006 · PROMETHEUS IBD Serology 7 is state of the art technology and the first commercially available IBD test that employs SDA technology to analyze markers of disease. The SDA pattern recognition algorithm adds analytical power and increases the accuracy of the new test compared to previous serologic tests, adding confidence to treatment decisions.

  7. PROMETHEUS© IBD Serology 7 is the most comprehensive Inflammatory Bowel Disease test available. This test is a blood test to help your physician determine if you have Inflammatory Bowel Disease (IBD), and if so, which type: Ulcerative Colitis or Crohn’s Disease. The test includes markers to detect various antibodies thought to be linked to IBD.

  8. Jul 10, 2006 · Prometheus Laboratories Inc., a specialty pharmaceutical company announced today that it has launched PROMETHEUS IBD Serology 7, the Company's most advanced diagnostic panel for inflammatory bowel disease.

  1. People also search for